Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.

Michaud-Levesque J, Bousquet-Gagnon N, Béliveau R.

Exp Cell Res. 2012 May 1;318(8):925-35. doi: 10.1016/j.yexcr.2012.02.017. Epub 2012 Feb 26.

PMID:
22394507
2.

Preexposure prophylaxis with albumin-conjugated C34 peptide HIV-1 fusion inhibitor in SCID-hu Thy/Liv mice.

Stoddart CA, Nault G, Galkina SA, Bousquet-Gagnon N, Bridon D, Quraishi O.

Antimicrob Agents Chemother. 2012 Apr;56(4):2162-5. doi: 10.1128/AAC.05015-11. Epub 2012 Jan 17.

3.

Albumin-conjugated C34 peptide HIV-1 fusion inhibitor: equipotent to C34 and T-20 in vitro with sustained activity in SCID-hu Thy/Liv mice.

Stoddart CA, Nault G, Galkina SA, Thibaudeau K, Bakis P, Bousquet-Gagnon N, Robitaille M, Bellomo M, Paradis V, Liscourt P, Lobach A, Rivard ME, Ptak RG, Mankowski MK, Bridon D, Quraishi O.

J Biol Chem. 2008 Dec 5;283(49):34045-52. doi: 10.1074/jbc.M805536200. Epub 2008 Sep 22.

4.

A covalent inhibitor targeting an intermediate conformation of the fusogenic subunit of the HIV-1 envelope complex.

Jacobs A, Quraishi O, Huang X, Bousquet-Gagnon N, Nault G, Francella N, Alvord WG, Pham N, Soucy C, Robitaille M, Bridon D, Blumenthal R.

J Biol Chem. 2007 Nov 2;282(44):32406-13. Epub 2007 Aug 28.

5.

Synthesis and evaluation of insulin-human serum albumin conjugates.

Thibaudeau K, Léger R, Huang X, Robitaille M, Quraishi O, Soucy C, Bousquet-Gagnon N, van Wyk P, Paradis V, Castaigne JP, Bridon D.

Bioconjug Chem. 2005 Jul-Aug;16(4):1000-8.

PMID:
16029043
6.

Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7-36) analog.

Léger R, Thibaudeau K, Robitaille M, Quraishi O, van Wyk P, Bousquet-Gagnon N, Carette J, Castaigne JP, Bridon DP.

Bioorg Med Chem Lett. 2004 Sep 6;14(17):4395-8.

PMID:
15357960
7.

Synthesis and in vitro analysis of atrial natriuretic peptide-albumin conjugates.

Léger R, Robitaille M, Quraishi O, Denholm E, Benquet C, Carette J, van Wyk P, Pellerin I, Bousquet-Gagnon N, Castaigne JP, Bridon D.

Bioorg Med Chem Lett. 2003 Oct 20;13(20):3571-5.

PMID:
14505673
8.

Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells.

Annabi B, Thibeault S, Lee YT, Bousquet-Gagnon N, Eliopoulos N, Barrette S, Galipeau J, Béliveau R.

Exp Hematol. 2003 Jul;31(7):640-9.

PMID:
12842709
9.

Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells.

Annabi B, Lachambre MP, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R.

Biochim Biophys Acta. 2002 Jan 30;1542(1-3):209-20.

10.

Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP).

Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre MP, Annabi B, Béliveau R.

FEBS Lett. 2001 Oct 26;507(2):231-6.

11.

Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.

Annabi B, Pilorget A, Bousquet-Gagnon N, Gingras D, Béliveau R.

Biochem J. 2001 Oct 15;359(Pt 2):325-33.

12.

Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains.

Annabi B, Lachambre M, Bousquet-Gagnon N, Pagé M, Gingras D, Béliveau R.

Biochem J. 2001 Feb 1;353(Pt 3):547-53.

Supplemental Content

Loading ...
Support Center